Select Page
Treatment of Huntington’s disease

Treatment of Huntington’s disease

Huntington’s disease (HD) is a dominantly inherited neurodegenerative disease due to CAG expansion in the huntingtin gene. Through a screening on polyQ-hHTT aggregation in HeLa cells, F. Maschat (CNRS Montpellier) recently identified an inhibitory 23aa peptide (P42)...
Protection of healthy tissues in cancer radiotherapy

Protection of healthy tissues in cancer radiotherapy

Many patients suffer adverse effects from radiation therapy. These side effects may be acute, occurring during or within a few weeks after therapy, or intermediate to late, occurring months to years after therapy. This risk is higher in younger patients in part...